CIK 0001750284
- Non-accelerated filer
- Smaller reporting company
Olema Oncology, Inc.
Sign in to watch- Ticker
- OLMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 300409740
- Phone
- +1 415-651-3316
- Business address
- 365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Olema Pharmaceuticals, Inc.
- 4/A Open-market buy PRESIDENT AND CEO bought 20,000 shares
- 4 Grant or award PRESIDENT AND CEO acquired 20,000 shares (grant or award)
- 4 Open-market buy CH. OPERATING & FINANCIAL OFF. bought 20,000 shares
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 200,000 shares at $4.03 ($806,900)
- 4 Open-market sale CHIEF BUSINESS OFFICER sold 5,253 shares at $4.75 ($24,952)
- 4 Option exercise CHIEF BUSINESS OFFICER acquired 5,251 shares (option exercise)
Page 8 of 13 · 244 filings